By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aquinox Pharmaceuticals 

5600 Parkwood Way
Suite 430
Richmond  British Columbia  V6V 2M2  U.S.A.
Phone: 604-629-9223 Fax: 604-295-4748


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Aquinox (AQXP) Announces Closing Of $75.4 Million Public Offering Of Common Stock, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares 9/26/2016 7:59:54 AM
Aquinox (AQXP) Announces Closing Of $75.4 Million Public Offering Of Common Stock, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares 9/26/2016 7:31:22 AM
Aquinox (AQXP) Announces Proposed Public Offering Of Common Stock 9/20/2016 8:58:22 AM
Aquinox (AQXP) Prices Public Offering Of Common Stock 9/20/2016 8:29:28 AM
Aquinox (AQXP) Initiates Patient Dosing In LEADERSHIP 301 Phase III Clinical Trial Of AQX-1125 In Interstitial Cystitis/Bladder Pain Syndrome 9/6/2016 8:43:20 AM
Aquinox (AQXP) Announces Second Quarter 2016 Financial Results 8/5/2016 10:40:01 AM
Aquinox (AQXP) To Announce Second Quarter 2016 Financial Results 8/2/2016 8:40:25 AM
Aquinox (AQXP) To Present At Canaccord Genuity 36th Annual Growth Conference 8/1/2016 8:35:33 AM
Aquinox (AQXP) To Announce Second Quarter 2016 Financial Results 8/1/2016 8:33:10 AM
Aquinox (AQXP) Announces Update On Development Program For AQX-1125 Following Meeting With FDA 1/11/2016 8:11:13 AM
12345
//-->